` IDIA (Idorsia Ltd) vs Swiss Market Index Comparison - Alpha Spread

IDIA
vs
Swiss Market Index

Over the past 12 months, IDIA has underperformed Swiss Market Index, delivering a return of -38% compared to the Swiss Market Index's 2% growth.

Stocks Performance
IDIA vs Swiss Market Index

Loading
IDIA
Swiss Market Index
Add Stock
www.alphaspread.com

Performance Gap
IDIA vs Swiss Market Index

Loading
IDIA
Swiss Market Index
Difference
www.alphaspread.com

Performance By Year
IDIA vs Swiss Market Index

Loading
IDIA
Swiss Market Index
Add Stock

Competitors Performance
Idorsia Ltd vs Peers

Swiss Market Index
IDIA
ABBV
AMGN
GILD
VRTX
Add Stock

Idorsia Ltd
Glance View

Market Cap
369.1m CHF
Industry
Biotechnology

Idorsia Ltd. operates as a biopharmaceutical firm which focuses on discovery, development and commercialization of innovative medicines for unmet medical needs. The company is headquartered in Allschwil, Basel-Landschaft. The company went IPO on 2017-06-16. The firm will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The firm's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.

IDIA Intrinsic Value
12.41 CHF
Undervaluation 87%
Intrinsic Value
Price
Back to Top